Nuvig Therapeutics

We are #hiring an Office Manager / Administrative Assistant! This role will support day-to-day operations and executive leadership while helping build a collaborative, high-performing workplace at a growing biotech focused on autoimmune disease. nuvigtherapeutics.com/careers/

How do you keep momentum when capital is tight and expectations are higher than ever? Our CEO, David Woodhouse, joined leaders from @ArrowheadPharma and @alpha_cognition for a @FiercePharma panel to discuss. Register to watch on-demand: bit.ly/48AfLpG

We’re pleased to welcome Celia J.F. Lin, M.D., as Chief Medical Officer. A rheumatologist and clinical development leader, Dr. Lin will guide NVG-2089 through Phase 2 studies and advance our BESTech™ platform for autoimmune disease. nuvigtherapeutics.com/nuvig-therapeu…

We’re honored to be named one of @FierceBiotech’s 2025 Fierce 15! Nuvig is advancing NVG-2089, a recombinant Fc-fragment designed to offer a potent, patient-friendly alternative to IVIG in #autoimmunedisease, now in Phase 2 clinical trials. fiercebiotech.com/special-report… #Fierce15

Today we welcome David J. Woodhouse as CEO and share that James Mackay will now serve as Independent BOD Chair. We look forward to their leadership as we advance NVG-2089 in Phase 2 #clinicaltrials in #autoimmunedisease and expand our BESTech™ platform. nuvigtherapeutics.com/nuvig-therapeu…

How can IVIG’s anti-inflammatory effects be delivered with less patient burden? We spoke with @neurology_live about how NVG-2089, in #clinicaltrials for CIDP, may offer similar benefit at lower doses and shorter infusion times. neurologylive.com/view/early-dat… neurologylive.com/view/rationale…

We’re pleased to share that we’ve dosed the first patient in our Phase 2 CIDP trial evaluating NVG-2089, a recombinant Fc fusion protein designed to replicate key immunomodulatory functions of IVIg with improved consistency and convenience. nuvigtherapeutics.com/nuvig-therapeu…

We’re proud to be featured in @Forbes as a biotech reshaping #autoimmunedisease treatment. Our lead candidate, NVG-2089, has the potential to be a potent, patient-friendly alternative to IVIG and is now entering Phase 2 clinical trials. forbes.com/sites/juergene… #biotechstowatch

Honored to be named one of the U.S. #biotech companies to watch by @DDWJournal. Nuvig is advancing novel, non-immunosuppressive therapies to restore immune balance and improve outcomes for patients with #autoimmunedisease. Read more: ddw-online.com/who-should-we-… #biotechstowatch

We’re looking for a (Sr.) Clinical Research Associate! Join us and help advance innovative therapies for #autoimmunediseases. If you have clinical trial experience & want to make an impact, apply today: nuvigtherapeutics.com/careers/ #biotech #clinicalresearch #hiring

We’re excited to announce a $161M Series B #financing to advance our innovative, non-immunosuppressive therapies for #autoimmunediseases and the progression of our lead program into Phase 2 #clinicaltrials Thank you to our investors for your support! nuvigtherapeutics.com/nuvig-therapeu…

We are #hiring a Staff Accountant! If you’re passionate about precision, numbers, and supporting breakthrough scientific innovation, this is your opportunity to grow with us! See the #openposition here: nuvigtherapeutics.com/careers/ #biotech #BayArea #careers #wearehiring

We are #hiring a Director of Regulatory Affairs! If you're an expert in navigating the complex world of biotech regulations and passionate about advancing innovative therapies, see the #openposition here: nuvigtherapeutics.com/careers/ #biotech #BayArea #careers #wearehiring

Are you passionate about supporting a great team that is working to advance new medicines for those affected by autoimmune disease? We are #hiring a Manager, Clinical Supply Chain! Learn more: nuvigtherapeutics.com/careers/ #biotech #BayArea #careers #wearehiring #openposition

Are you passionate about supporting a great team that is working to advance new medicines for those affected by autoimmune disease? We are #hiring an #ExecutiveAssistant! Learn more: nuvigtherapeutics.com/careers/ #biotech #BayArea #careers #wearehiring #openposition

Are you passionate about advancing novel therapeutics for those affected by #autoimmune disease? We're #hiring a #ClinicalTrial Manager, Director/Sr. Director #ClinicalOperations, & Sr. Medical Director Learn more: nuvigtherapeutics.com/careers/ #biotech #BayArea #clinicaldevelopment

Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089 nuvigtherapeutics.com/nuvig-initiate…

We welcome Dr. Alan Glicklich as our new CMO! With 25+ years of experience advancing novel drug candidates and building teams to ensure quality and safety, his leadership will advance our innovative drug candidates for chronic #autoimmunediseases. nuvigtherapeutics.com/nuvig-therapeu…

We are thrilled to welcome Bella Oguno as VP of Development Operations and Karen Grimm as Senior Director of Analytical Development to the Nuvig Therapeutics team. Their leadership and experience will be key to helping us develop innovative therapies for #autoimmunediseases.

Are you passionate about advancing novel therapeutics for those affected by #autoimmune disease? We are #hiring a Medical Director, VP & Director of #ClinicalOperations, and VP of #RegulatoryAffairs. #JoinUs: nuvigtherapeutics.com/careers/ #biotech #hematologist #clinicaldevelopment